India CDMO Industry: Trends, Size, Growth and Market Forecast 2025-2033

India CDMO Market 2025-2033

According to IMARC Group's report titled "India CDMO Market Size, Share, Trends and Forecast by Service Type, Type, Scale of Operation, Therapeutic Area, and Region, 2025-2033", The report offers a comprehensive analysis of the industry, including market share, growth, trends, and regional insights.

How Big is the India CDMO Industry ?

The India CDMO Industry size was valued at USD 7.9 Billion in 2024 and is expected to reach USD 15.4 Billion by 2033, exhibiting a growth rate (CAGR) of 7.7% during 2025-2033.

India CDMO Market Trends:

The Indian Contract Development and Manufacturing Organization (CDMO) market is experiencing dynamic shifts, driven by global pharmaceutical outsourcing and domestic capabilities. A prominent trend is the increasing preference for end-to-end solutions, where CDMOs offer integrated services from drug development to commercial-scale manufacturing, reducing time-to-market for clients. Moreover, the growing adoption of advanced technologies like continuous manufacturing and artificial intelligence is enhancing process efficiency and product quality, positioning India as a competitive global player.

In addition, the rise of biologics and complex generics has spurred demand for specialized CDMOs with expertise in biosimilars and injectables. Furthermore, strategic collaborations between Indian CDMOs and multinational pharma companies are expanding, fueled by cost advantages and regulatory compliance with international standards. Basically, the emphasis on regulatory excellence is becoming a key differentiator, as Indian firms increasingly secure approvals from stringent agencies like the US FDA and EMA. Notably, the shift toward sustainable practices is gaining momentum, with green chemistry and waste reduction initiatives aligning with global ESG norms. Additionally, the expansion of fill-finish capabilities for vaccines and biologics reflects India's strengthened role in global health security post-pandemic.

Request for a sample copy of this report: https://www.imarcgroup.com/india-cdmo-market/requestsample

India CDMO Market Scope and Growth Analysis:

India's CDMO market holds immense growth potential, supported by its robust pharmaceutical ecosystem and evolving global demand. Moreover, the increasing outsourcing by Big Pharma to reduce R&D costs and capitalize on India's skilled workforce is driving market expansion. In addition, the government's production-linked incentive (PLI) schemes for pharmaceuticals are accelerating investments in high-value manufacturing and innovation. Furthermore, the untapped potential in novel drug delivery systems and personalized medicine presents lucrative opportunities for CDMOs to diversify their service portfolios.

Basically, the growing domestic healthcare needs and export-oriented policies are creating a dual-engine growth model, balancing local and international demand. The market also benefits from India's strong position in the global generic drugs market, which naturally extends to CDMO services for off-patent molecules. With the convergence of technology and traditional manufacturing, Indian CDMOs are well-positioned to lead in next-generation therapies like cell and gene treatments. Overall, the combination of policy support, technological adoption, and global partnerships ensures sustained growth, solidifying India's role as a key hub for pharmaceutical development and manufacturing.

India CDMO Industry Segmentation:

The report has segmented the market into the following categories:

Service Type Insights:

Contract Development Services

Preclinical Development
Clinical Development
Analytical and Bioanalytical Services

Contract Manufacturing Services

Active Pharmaceutical Ingredients (APIs) Manufacturing
Finished Dosage Forms (FDFs) Manufacturing
Biologics Manufacturing
Packaging

Type Insights:

Small Molecules
Biologics
Biosimilars
Vaccines
Others

Scale of Operation Insights:

Commercial Scale
Clinical Scale

Therapeutic Area Insights:

Oncology
Cardiovascular Diseases
Infectious Diseases
Central Nervous System (CNS) Disorders
Others

Regional Insights:

North India
South India
East India
West India

Competitor Landscape:

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

Other key areas covered in the report:

COVID-19 Impact on the Market
Porter’s Five Forces Analysis
Strategic Recommendations
Market Dynamics
Historical, Current and Future Market Trends
Market Drivers and Success Factors
SWOT Analysis
Value Chain Analysis
Comprehensive Mapping of the Competitive Landscape
Top Winning Strategies
Recent Industry News
Key Technological Trends & Development

Ask an analyst: https://www.imarcgroup.com/request?type=report&id=30719&flag=C

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-201971-6302